XML 22 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 276 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Revenues:      
Product sales and rentals $ 2 $ 9 $ 1,879
Research and development agreements     2,105
Grants     9,901
Total revenues 2 9 13,885
Costs and expenses:      
Cost of product sales and rentals 2 2 3,043
Research and development 6,796 4,372 197,501
Selling, general and administrative 1,762 1,895 86,610
Total costs and expenses 8,560 6,269 287,154
Loss from operations (8,558) (6,260) (273,269)
Other income (expense):      
(Increase) decrease in fair value of warrants (900) 1,254 11,389
Other income     1,249
Interest income 6 20 10,778
Interest expense (3) (2) (482)
Total other income (expense) (897) 1,272 22,934
Net loss (9,455) (4,988) (250,335)
Accretion of convertible preferred stock 289   1,257
Net loss attributable to common shareholders $ (9,744) $ (4,988) $ (251,592)
Net loss per share attributable to common shareholders (Basic and Diluted) (in dollars per share) $ (0.25) $ (0.13)  
Weighted average number of common shares outstanding (Basic) (in shares) 38,742 38,617  
Weighted average number of common shares outstanding (Diluted) (in shares) 38,742 38,617